chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Miserable; Sleeping a lot; headache; fatigue; Nausea; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Miserable), HYPERSOMNIA (Sleeping a lot), HEADACHE (headache), FATIGUE (fatigue) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced FEELING ABNORMAL (Miserable), HYPERSOMNIA (Sleeping a lot), HEADACHE (headache), FATIGUE (fatigue), NAUSEA (Nausea) and CHILLS (Chills). At the time of the report, FEELING ABNORMAL (Miserable), HYPERSOMNIA (Sleeping a lot), HEADACHE (headache), FATIGUE (fatigue), NAUSEA (Nausea) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.   Reporter did not allow further contact
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Felt like he had COVID-19 virus again; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Felt like he had COVID-19 virus again) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (was hospitalized) in October 2020.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced COVID-19 (Felt like he had COVID-19 virus again). At the time of the report, COVID-19 (Felt like he had COVID-19 virus again) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported on the same evening (as his vaccine) he just felt sick, but this morning he felt better.  No concomitant medication use was provided by the reporter.  Treatment of events was not reported.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure measurement, Dizziness, Hypertension
Clinical narrative: Very high blood pressure; Dizziness; Weakness; This spontaneous case was reported by a patient family member or friend and describes the occurrence of HYPERTENSION (Very high blood pressure), DIZZINESS (Dizziness) and ASTHENIA (Weakness) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Glaucoma.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced DIZZINESS (Dizziness) and ASTHENIA (Weakness). On 11-Mar-2021, the patient experienced HYPERTENSION (Very high blood pressure). At the time of the report, HYPERTENSION (Very high blood pressure) outcome was unknown and DIZZINESS (Dizziness) and ASTHENIA (Weakness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient took treatment medications for High  Blood pressure.   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: Additional TCR form is received which does not contain any new information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pollakiuria
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of POLLAKIURIA (Excessive urination) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 032M20A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced POLLAKIURIA (Excessive urination). On 11-Mar-2021, POLLAKIURIA (Excessive urination) had resolved. Not Provided. Concomitant medications were not provided by the reporter. Treatment information was not provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue
Clinical narrative: shortness of breath; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath) and FATIGUE (fatigue) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse drug reaction (medical history was not reported.).    On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced DYSPNOEA (shortness of breath) and FATIGUE (fatigue). At the time of the report, DYSPNOEA (shortness of breath) and FATIGUE (fatigue) outcome was unknown.            No concomitant medications was reported Treatment information was not provided
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Vaccination site swelling
Clinical narrative: Injection site erythema; Bump at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Injection site erythema) and VACCINATION SITE SWELLING (Bump at injection site) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (Injection site erythema) and VACCINATION SITE SWELLING (Bump at injection site). At the time of the report, INJECTION SITE ERYTHEMA (Injection site erythema) and VACCINATION SITE SWELLING (Bump at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter wanted to know if patient can get her second dose with an upset stomach.  Concomitant medications were not reported. Treatment information in response to events was not provided.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Electrocardiogram, Hypoaesthesia, Magnetic resonance imaging, Paraesthesia
Clinical narrative: numbness and pins and needles on her right foot and arm; left arm started going numb; numbness in the left part of her foot, throughout the day it spread to her leg; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA (numbness in the left part of her foot, throughout the day it spread to her leg), HYPOAESTHESIA (left arm started going numb) and PARAESTHESIA (numbness and pins and needles on her right foot and arm) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A121A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine. Concomitant products included Birth Control (CONTRACEPTIVES) for Birth control, TOPIRAMATE for Migraine.    On 06-Mar-2021 at 5:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced HYPOAESTHESIA (numbness in the left part of her foot, throughout the day it spread to her leg). On 10-Mar-2021, the patient experienced HYPOAESTHESIA (left arm started going numb). On 11-Mar-2021, the patient experienced PARAESTHESIA (numbness and pins and needles on her right foot and arm). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (numbness in the left part of her foot, throughout the day it spread to her leg), HYPOAESTHESIA (left arm started going numb) and PARAESTHESIA (numbness and pins and needles on her right foot and arm) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Computerised tomogram: normal (normal) normal. On 10-Mar-2021, Electrocardiogram: normal (normal) normal. On 10-Mar-2021, Magnetic resonance imaging: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient went to urgent care on 08MAR2021 due to spreading numbness on the left side and was told it was a normal side effect and to rest and take OTC ibuprofen. On 10MAR2021 the patient went to the ER due to numbness in arm and all tests were normal.  No additional treatment information was provided.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Dysgeusia, Fatigue, Movement disorder
Clinical narrative: dizzy; hard to move; fatigue; muscle ache; chills; bad taste in mouth; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (bad taste in mouth), DIZZINESS (dizzy), MOVEMENT DISORDER (hard to move), CHILLS (chills) and FATIGUE (fatigue) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced DYSGEUSIA (bad taste in mouth), CHILLS (chills) and MYALGIA (muscle ache). On 11-Mar-2021, the patient experienced DIZZINESS (dizzy), MOVEMENT DISORDER (hard to move) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSGEUSIA (bad taste in mouth), DIZZINESS (dizzy), MOVEMENT DISORDER (hard to move), CHILLS (chills), FATIGUE (fatigue) and MYALGIA (muscle ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       treatment included: some pills to sleep. No concomitant medications reported.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: dizzy; hard to move; fatigue; muscle ache; chills; bad taste in mouth; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (bad taste in mouth), DIZZINESS (dizzy), MOVEMENT DISORDER (hard to move), CHILLS (chills) and FATIGUE (fatigue) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced DYSGEUSIA (bad taste in mouth), CHILLS (chills) and MYALGIA (muscle ache). On 11-Mar-2021, the patient experienced DIZZINESS (dizzy), MOVEMENT DISORDER (hard to move) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSGEUSIA (bad taste in mouth), DIZZINESS (dizzy), MOVEMENT DISORDER (hard to move), CHILLS (chills), FATIGUE (fatigue) and MYALGIA (muscle ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       treatment included: some pills to sleep. No concomitant medications reported.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash, Vaccination complication, Vaccination site induration, Vaccination site swelling
Clinical narrative: rash on upper left arm; hardness(injection site); swelling (injection site); sore arm; Patient believes injection was administered too quickly; felt so much pressure; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION COMPLICATION (Patient believes injection was administered too quickly; felt so much pressure), RASH (rash on upper left arm), VACCINATION SITE INDURATION (hardness(injection site)) and VACCINATION SITE SWELLING (swelling (injection site)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION COMPLICATION (Patient believes injection was administered too quickly; felt so much pressure). On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 10-Mar-2021, the patient experienced RASH (rash on upper left arm), VACCINATION SITE INDURATION (hardness(injection site)) and VACCINATION SITE SWELLING (swelling (injection site)). On 01-Mar-2021, VACCINATION COMPLICATION (Patient believes injection was administered too quickly; felt so much pressure) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm), RASH (rash on upper left arm), VACCINATION SITE INDURATION (hardness(injection site)) and VACCINATION SITE SWELLING (swelling (injection site)) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 11-Mar-2021: Reporter details provided, vaccine details provided, event outcome (ongoing) provided
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: hard to breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (hard to breath) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced DYSPNOEA (hard to breath). At the time of the report, DYSPNOEA (hard to breath) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  4 days after receiving the first vaccine dose, the patient was having trouble breathing. The wife eventually called an ambulance. The wife reported that her husband is "ok now."   It is unknown whether the patient received his second planned dose scheduled on 16MAR2021.    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Antibody test negative, Blood immunoglobulin G, Blood immunoglobulin M
Clinical narrative: antibody test negative after receiving 1st and 2nd dose of vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of ANTIBODY TEST NEGATIVE (antibody test negative after receiving 1st and 2nd dose of vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient experienced ANTIBODY TEST NEGATIVE (antibody test negative after receiving 1st and 2nd dose of vaccine). At the time of the report, ANTIBODY TEST NEGATIVE (antibody test negative after receiving 1st and 2nd dose of vaccine) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Blood immunoglobulin G:. On 10-Mar-2021, Blood immunoglobulin M:.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment information in response to events was not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Oropharyngeal pain, Pain in extremity, Pyrexia
Clinical narrative: sore arm; sore throat; low grade temperature; felt like she was having the flu; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), OROPHARYNGEAL PAIN (sore throat), PYREXIA (low grade temperature) and INFLUENZA LIKE ILLNESS (felt like she was having the flu) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), OROPHARYNGEAL PAIN (sore throat), PYREXIA (low grade temperature) and INFLUENZA LIKE ILLNESS (felt like she was having the flu). On 09-Mar-2021, PAIN IN EXTREMITY (sore arm), OROPHARYNGEAL PAIN (sore throat), PYREXIA (low grade temperature) and INFLUENZA LIKE ILLNESS (felt like she was having the flu) had resolved.            Action taken with the mRNA-1273 in response to the events was considered as not applicable.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Incorrect product formulation administered
Clinical narrative: got two different vaccines/ invalid dose (First dose from Moderna and second dose from Pfizer); felt tired after first dose; no energy after first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of ASTHENIA (no energy after first dose), INCORRECT PRODUCT FORMULATION ADMINISTERED (got two different vaccines/ invalid dose (First dose from Moderna and second dose from Pfizer)) and FATIGUE (felt tired after first dose) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced ASTHENIA (no energy after first dose) and FATIGUE (felt tired after first dose). On an unknown date, the patient experienced INCORRECT PRODUCT FORMULATION ADMINISTERED (got two different vaccines/ invalid dose (First dose from Moderna and second dose from Pfizer)). At the time of the report, ASTHENIA (no energy after first dose) and FATIGUE (felt tired after first dose) outcome was unknown and INCORRECT PRODUCT FORMULATION ADMINISTERED (got two different vaccines/ invalid dose (First dose from Moderna and second dose from Pfizer)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.   No treatment information was provided.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Photopsia
Clinical narrative: Developed flashing light in his eyes; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PHOTOPSIA (Developed flashing light in his eyes) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PHOTOPSIA (Developed flashing light in his eyes). At the time of the report, PHOTOPSIA (Developed flashing light in his eyes) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported that he did not receive treatment for his symptoms. He visited opthalmologist.
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Myalgia, Nausea, Pain
Clinical narrative: pain; all bones hurt; feel like throw up; aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain), BONE PAIN (all bones hurt), NAUSEA (feel like throw up) and MYALGIA (aches) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     The patient's past medical history included Pacemaker generated rhythm since an unknown date. Concurrent medical conditions included Congestive heart failure.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN (pain), BONE PAIN (all bones hurt), NAUSEA (feel like throw up) and MYALGIA (aches). On 11-Mar-2021, PAIN (pain), BONE PAIN (all bones hurt), NAUSEA (feel like throw up) and MYALGIA (aches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  No treatment information was provided.   This case was linked to MOD-2021-230251 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: F/U-1 : AE details of Dose 2
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Palpitations, Rash
Clinical narrative: severe case of shingles including enteric shingles; heart palpitations; rash; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (severe case of shingles including enteric shingles), PALPITATIONS (heart palpitations) and RASH (rash) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028l20a) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced HERPES ZOSTER (severe case of shingles including enteric shingles), PALPITATIONS (heart palpitations) and RASH (rash). At the time of the report, HERPES ZOSTER (severe case of shingles including enteric shingles), PALPITATIONS (heart palpitations) and RASH (rash) outcome was unknown.            No concomitant medications were provided by the reporter.  The patient stated she was unable to get any antiviral medications because she had just been vaccinated. 6 weeks passed and she began to feel better.   This case was linked to MOD-2021-040781 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow up received on 22-JUN-2021 contains  No NewInformation
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort
Clinical narrative: Discomfort in injection arm; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Discomfort in injection arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Discomfort in injection arm). At the time of the report, LIMB DISCOMFORT (Discomfort in injection arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.   Reporter did not allow further contact
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Fatigue, Nausea, Pyrexia
Clinical narrative: low grade fever (99.2); weakness; severe nausea; tired; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), NAUSEA (severe nausea), FATIGUE (tired) and PYREXIA (low grade fever (99.2)) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ASTHENIA (weakness), NAUSEA (severe nausea) and FATIGUE (tired). On 10-Mar-2021, the patient experienced PYREXIA (low grade fever (99.2)). The patient was treated with AMMONIUM CHLORIDE, CAMPHOR, SALICYLATE SODIUM, STRYCHNINE SULFATE (PEPTOL) at an unspecified dose and frequency; ONDANSETRON (ZOFRAN [ONDANSETRON]) at an unspecified dose and frequency; IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 11-Mar-2021, PYREXIA (low grade fever (99.2)) outcome was unknown. At the time of the report, ASTHENIA (weakness), NAUSEA (severe nausea) and FATIGUE (tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Body temperature: 99.2 (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment for the events also included anti-nausea medication
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Pyrexia
Clinical narrative: Arm hurts; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurts), HEADACHE (Headache) and PYREXIA (Fever) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm hurts), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Arm hurts), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional concomitant product used included thyroid medication NOS and herbal medication NOS.  Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow-up information received on 10-May-2021 and doe not contain any new information.
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Insomnia, Pain
Clinical narrative: extreme pain; can't sleep; can't sit; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (extreme pain), INSOMNIA (can't sleep) and DISCOMFORT (can't sit) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (extreme pain), INSOMNIA (can't sleep) and DISCOMFORT (can't sit). At the time of the report, PAIN (extreme pain), INSOMNIA (can't sleep) and DISCOMFORT (can't sit) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Arms were red; Itching from shoulder to elbow; Broke out on arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arms were red), PRURITUS (Itching from shoulder to elbow) and RASH (Broke out on arm) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013a21a) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced ERYTHEMA (Arms were red), PRURITUS (Itching from shoulder to elbow) and RASH (Broke out on arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Arms were red), PRURITUS (Itching from shoulder to elbow) and RASH (Broke out on arm) outcome was unknown.            Concomitant product use was not provided by the reporter.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the event is not applicable.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Device connection issue, Headache, Hyperhidrosis, Injection site erythema
Clinical narrative: Swelling is spreading down my arm; Arm at the injection site is red; Arm at the injection site is swollen; Headache; Temperature on and off; Cold; Sweat; Achy; Chills; Nurse put the needle in my arm and the syringe broke; This spontaneous case was reported by a consumer and describes the occurrence of DEVICE CONNECTION ISSUE (Nurse put the needle in my arm and the syringe broke), NASOPHARYNGITIS (Cold), PERIPHERAL SWELLING (Swelling is spreading down my arm), HYPERHIDROSIS (Sweat) and PAIN (Achy) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DEVICE CONNECTION ISSUE (Nurse put the needle in my arm and the syringe broke). On 09-Mar-2021, the patient experienced NASOPHARYNGITIS (Cold), HYPERHIDROSIS (Sweat), PAIN (Achy), CHILLS (Chills) and PYREXIA (Temperature on and off). On 10-Mar-2021, the patient experienced HEADACHE (Headache). On an unknown date, the patient experienced PERIPHERAL SWELLING (Swelling is spreading down my arm), INJECTION SITE ERYTHEMA (Arm at the injection site is red) and VACCINATION SITE SWELLING (Arm at the injection site is swollen). The patient was treated with NAPROXEN (MOTRIN [NAPROXEN]) at an unspecified dose and frequency. On 10-Mar-2021, PAIN (Achy) had resolved. At the time of the report, DEVICE CONNECTION ISSUE (Nurse put the needle in my arm and the syringe broke), NASOPHARYNGITIS (Cold), PERIPHERAL SWELLING (Swelling is spreading down my arm), HYPERHIDROSIS (Sweat), CHILLS (Chills), HEADACHE (Headache), INJECTION SITE ERYTHEMA (Arm at the injection site is red), VACCINATION SITE SWELLING (Arm at the injection site is swollen) and PYREXIA (Temperature on and off) outcome was unknown.            No concomitant medications were provided. The patient reported that when nurse put the needle in her arm, the syringe broke, and the vaccine dripped down her arm, but then, the nurse gave her another dose.   .
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pain, Peripheral swelling, Pyrexia, Vaccination site swelling
Clinical narrative: Swelling is spreading down my arm; Arm at the injection site is red; Arm at the injection site is swollen; Headache; Temperature on and off; Cold; Sweat; Achy; Chills; Nurse put the needle in my arm and the syringe broke; This spontaneous case was reported by a consumer and describes the occurrence of DEVICE CONNECTION ISSUE (Nurse put the needle in my arm and the syringe broke), NASOPHARYNGITIS (Cold), PERIPHERAL SWELLING (Swelling is spreading down my arm), HYPERHIDROSIS (Sweat) and PAIN (Achy) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DEVICE CONNECTION ISSUE (Nurse put the needle in my arm and the syringe broke). On 09-Mar-2021, the patient experienced NASOPHARYNGITIS (Cold), HYPERHIDROSIS (Sweat), PAIN (Achy), CHILLS (Chills) and PYREXIA (Temperature on and off). On 10-Mar-2021, the patient experienced HEADACHE (Headache). On an unknown date, the patient experienced PERIPHERAL SWELLING (Swelling is spreading down my arm), INJECTION SITE ERYTHEMA (Arm at the injection site is red) and VACCINATION SITE SWELLING (Arm at the injection site is swollen). The patient was treated with NAPROXEN (MOTRIN [NAPROXEN]) at an unspecified dose and frequency. On 10-Mar-2021, PAIN (Achy) had resolved. At the time of the report, DEVICE CONNECTION ISSUE (Nurse put the needle in my arm and the syringe broke), NASOPHARYNGITIS (Cold), PERIPHERAL SWELLING (Swelling is spreading down my arm), HYPERHIDROSIS (Sweat), CHILLS (Chills), HEADACHE (Headache), INJECTION SITE ERYTHEMA (Arm at the injection site is red), VACCINATION SITE SWELLING (Arm at the injection site is swollen) and PYREXIA (Temperature on and off) outcome was unknown.            No concomitant medications were provided. The patient reported that when nurse put the needle in her arm, the syringe broke, and the vaccine dripped down her arm, but then, the nurse gave her another dose.   .
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: severe headache; slight headche; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (slight headche) and HEADACHE (severe headache) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced HEADACHE (slight headche). On 11-Mar-2021 at 3:00 AM, the patient experienced HEADACHE (severe headache). The patient was treated with MELATONIN at an unspecified dose and frequency. On 03-Mar-2021, HEADACHE (slight headche) had resolved. At the time of the report, HEADACHE (severe headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Rash, Skin burning sensation
Clinical narrative: Burning/stinging rash; Burning/stinging rash; This spontaneous case was reported by a consumer and describes the occurrence of SKIN BURNING SENSATION (Burning/stinging rash) and RASH (Burning/stinging rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Shingles.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN BURNING SENSATION (Burning/stinging rash) and RASH (Burning/stinging rash). At the time of the report, SKIN BURNING SENSATION (Burning/stinging rash) and RASH (Burning/stinging rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was reported  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Tremor
Clinical narrative: Shakiness; Nausea; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shakiness), NAUSEA (Nausea), HEADACHE (Headache) and FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TREMOR (Shakiness), NAUSEA (Nausea), HEADACHE (Headache) and FATIGUE (Fatigue). At the time of the report, TREMOR (Shakiness), NAUSEA (Nausea), HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Pain in extremity
Clinical narrative: Sore Arm; Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm) and INFLUENZA LIKE ILLNESS (Flu like symptoms) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Consumer had prior diagnosis of covid-19 in Nov/2020.) in November 2020.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm) and INFLUENZA LIKE ILLNESS (Flu like symptoms). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Sore Arm) and INFLUENZA LIKE ILLNESS (Flu like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Crosslinked to case MOD21-051579 Patient called to request assistance in filling out an adverse event form  that he received from  Moderna Safety  No concomitant product use was reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow up information received on 22 June 2021 contains no significant information
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Hot flush
Clinical narrative: Felt Odd; Flash of warm/flush; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt Odd) and HOT FLUSH (Flash of warm/flush) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A214) for COVID-19 vaccination.     Concomitant products included PANTOPRAZOLE for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced FEELING ABNORMAL (Felt Odd) and HOT FLUSH (Flash of warm/flush). At the time of the report, FEELING ABNORMAL (Felt Odd) and HOT FLUSH (Flash of warm/flush) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details not included.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: NNI
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Tenderness and aching in the arm; Swelled up; Vaccination site erythema; It was itchy, tender, and swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Tenderness and aching in the arm), VACCINATION SITE SWELLING (Swelled up), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PRURITUS (It was itchy, tender, and swollen) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Tenderness and aching in the arm), VACCINATION SITE SWELLING (Swelled up), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PRURITUS (It was itchy, tender, and swollen). At the time of the report, VACCINATION SITE PAIN (Tenderness and aching in the arm), VACCINATION SITE SWELLING (Swelled up), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PRURITUS (It was itchy, tender, and swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported Treatment includes: Patient reports icing her arm, but it made it worse. She also used a cool, wet cloth on her arm.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received 2 doses in 2 days; A spontaneous report was received from a physician concerning a patient of unspecified age and gender, who received one dose of Moderna's COVID-19 vaccine (mRNA-1273) and then received another dose on the next day/inappropriate schedule of product administration.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On an unknown date, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Batch Number: unknown) via unknown route at unknown anatomical location for prophylaxis of COVID-19 infection.  On the next day, after the first dose, the patient received the second of two planned doses of mRNA-1273 (Batch Number: unknown) for prophylaxis of COVID-19 infection. No treatment information was provided.  The reporter stated to his knowledge the patient did not experience any complications.  Action taken with mRNA-1273 in response to the event was unknown.    The outcome of the event, received two doses in two days, was considered as resolved.; Reporter's Comments: This report refers to a case of inappropriate schedule of vaccine administered for mRNA-1273 (lot #unknown) with no associated AEs reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included Tylenol.   This case was linked to MOD-2021-040891 (Patient Link).
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash
Clinical narrative: Weird rash; Red and patchy at the area she received the vaccine; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE RASH (Weird rash) and VACCINATION SITE ERYTHEMA (Red and patchy at the area she received the vaccine) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concomitant products included PAROXETINE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Weird rash) and VACCINATION SITE ERYTHEMA (Red and patchy at the area she received the vaccine). At the time of the report, VACCINATION SITE RASH (Weird rash) and VACCINATION SITE ERYTHEMA (Red and patchy at the area she received the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for Covid after the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for Covid after the 1st dose) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included RA. Concomitant products included PREDNISONE and METHOTREXATE for RA, PARACETAMOL (TYLENOL) and VITAMINS NOS for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced COVID-19 (Tested positive for Covid after the 1st dose). At the time of the report, COVID-19 (Tested positive for Covid after the 1st dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   Reporter did not allow further contact
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027a21a) for COVID-19 vaccination.     Previously administered products included for Anaphylactic reaction: Flu vaccine. Past adverse reactions to the above products included Anaphylactic reaction with Flu vaccine.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.   Reporter did not allow further contact